These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 399149)

  • 21. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin resistance in the uremic patient: effects of hemodialysis].
    Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
    Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure.
    Capaldo B; Cianciaruso B; Napoli R; Andreucci V; Kopple JD; Saccà L
    J Clin Endocrinol Metab; 1990 Jan; 70(1):127-33. PubMed ID: 2403570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone and carbohydrate intolerance in cirrhosis.
    Shankar TP; Solomon SS; Duckworth WC; Jerkins T; Iyer RS; Bobal MA
    Horm Metab Res; 1988 Sep; 20(9):579-83. PubMed ID: 3058569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma glucose and free fatty acids modulate the secretion of growth hormone, but not prolactin, in the rhesus and Java monkey.
    Quabbe HJ; Bunge S; Walz T; Bratzke B
    J Clin Endocrinol Metab; 1990 Apr; 70(4):908-15. PubMed ID: 2108186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management.
    Benedetti MM; Santeusanio F; Angeletti G; Filipponi P; Buoncristiani U; Brunetti P
    Acta Diabetol Lat; 1977; 14(5-6):235-49. PubMed ID: 613688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.
    De Marchi S; Cecchin E; Villalta D; Tesio F
    Clin Nephrol; 1987 Apr; 27(4):189-98. PubMed ID: 3581526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats.
    Chen SM; Young TK; Ho LT
    Diabetes Res Clin Pract; 1998 Aug; 41(2):85-94. PubMed ID: 9789714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired postprandial regulation of insulin-like growth factor binding protein-1 in children with chronic renal failure.
    Haffner D; Blum WF; Heinrich U; Mehls O; Tönshoff B
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2832-5. PubMed ID: 9284705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin, growth hormone and insulin in hemodialyzed uremic diabetics.
    Avram MM
    Artif Organs; 1978 Nov; 2(4):382-5. PubMed ID: 743011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.
    Schmitz O; Alberti KG; Christensen NJ; Hasling C; Hjøllund E; Beck-Nielsen H; Orskov H
    Metabolism; 1985 May; 34(5):465-73. PubMed ID: 3887103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose intolerance following chronic metabolic acidosis in man.
    DeFronzo RA; Beckles AD
    Am J Physiol; 1979 Apr; 236(4):E328-34. PubMed ID: 434194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and pituitary content of growth hormone luteinizing hormone, and prolactin in uremic rats. Effects of chronic infusion of insulin.
    Lacour B; Roullet JB; Bluet-Pajot MT; Yvert JP; Drüeke T; Durand D
    Nephron; 1986; 44(3):235-9. PubMed ID: 3537818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolactin response to acute administration of growth hormone releasing hormone in patients with uremia].
    García Martín F; Donnay Candil S; Martín Escobar E; Alvaro R; de Arriba G; Requejo R; Martín Hernández R
    Rev Clin Esp; 1989 Nov; 185(8):399-401. PubMed ID: 2516347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.